Dr. Jeffrey Flier is an endocrinologist and a professor at Harvard Medical School, where he was the dean from 2007 to 2016.

Hims & Hers Health (HIMS) is trying its best to stay relevant in the multi-billion dollar obesity treatment market. Despite a ...

Carrington College has named Nick Gomez as its new president, with a focus on expanding the college's footprint in Sacramento ...

Hims stock clawed higher Wednesday though analysts laid out low expectations for Him & Hers' branded tirzepatide.

Telehealth providers like Hims and Ro say they are helping fill ... often after simply filling out a questionnaire about their medical history, medications and treatment goals.

Hims & Hers Health, Inc operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health ...

Introduction: What Even Is Hims & Hers Health ... physicians, and other medical governing bodies, and that body of medicine is prescribed to patients who have a series of issues that commonly ...

I like how HIMS is combining a data-intense AI-assisted platform that can make a tech bro smile with sound practices based on respect for and working with human medical professionals. It’ll take ...

The knockoff surge was led by Hims & Hers Health, the telehealth firm that began selling the drugs last spring.

He emphasised that under the hub-and-spoke model, all medical colleges should be linked to the telemedicine services of KGMU, RML, and SGPGI, enabling patients to consult specialist doctors with ease.

In this article, we are going to take a look at where Hims & Hers Health Inc. (NYSE:HIMS) stands against other Wednesday’s top performers. The stock market regained momentum on Wednesday ...